mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.02 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |